Loading...

Fixation Buffer

Pricing & Availability
Regulatory Status
RUO
Other Names
Fixative, Paraformaldehyde
Ave. Rating
Submit a Review
Product Citations
publications
Cat # Size Price Quantity Check Availability Save
420801 100 mL DKK351
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

Fixation Buffer is useful for intracellular staining procedures, e.g., in preparation of cells for staining intracellular cytokines or other proteins. Fixation Buffer is used to fix cells prior to permeabilization using Permeabilization Wash Buffer (Cat. No. 421002). BioLegend's Fixation Buffer has been formulated with prescreened paraformaldehyde with low background, thus producing the greatest signal to noise ratio.

Product Details
Technical Data Sheet (pdf)

Product Details

Storage & Handling
This buffer solution should be stored between 2°C and 8°C.
Application

ICFC - Quality tested
ICC
Recommended Usage

For cell fixation, use 250 µL fixation buffer per tube and leave it in the dark for 20 minutes at room temperature. It is recommended that the reagent be titrated for optimal performance for each application. For the fixation procedure, please refer to the "Intracellular Cytokine Staining Protocol" under "Support" on BioLegend's website.
Caution: This buffer contains paraformaldehyde, which is toxigenic and mutagenic. Please handle with caution and wear gloves, lab coat and necessary protection to avoid direct body contacts.

Application Notes

This 1X PBS solution contains 4% paraformaldehyde, which is toxic and is a suspected carcinogen. Contact with eyes, skin and mucous membranes should be avoided.

Additional Product Notes

View more applications data using this product to stain Veri-Cells™ lyophilized control cells and to perform phospho-flow in our Scientific Poster Library.

Application References
  1. Kang YJ, et al. 2007. Nature Immunol. 8:601.
  2. Kenna TJ, et al. 2010. J. Immunol. 184:598. PubMed
  3. Sullivan BP, et al. 2010. Am J Pathol. 177:2837. PubMed
  4. del Rio ML, et al. 2011.Transplantation. 92:1085. PubMed
  5. del Rio ML, et al. 2012. J. Immunol. 188:4885. PubMed
  6. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  7. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  8. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
Product Citations
  1. Yokozeki Y, et al. 2021. Biomed Res Int. 2021:7988320. PubMed
  2. Tocheva AS, et al. 2020. Curr Protoc Immunol. 130:e103. PubMed
  3. Haberthur K, et al. 2013. J Virol. 87:11751. PubMed
  4. Li B, Schmidt N 2016. PLoS One. 11: 0162427. PubMed
  5. Salybekov AA, et al. 2018. PLoS One. 13:e0203244. PubMed
  6. Darzianiazizi M, et al. 2020. Int J Mol Sci. 21:00. PubMed
  7. Mirlekar B, et al. 2020. Cancer Immunol Res. 0.536111111. PubMed
  8. Shen Z, et al. 2020. Bioact Mater. 5:1113. PubMed
  9. Kim J, et al. 2021. Cytometry A. 99:807. PubMed
  10. Stoycheva D, et al. 2021. Eur J Immunol. 51:1423. PubMed
  11. Bruno MEC, et al. 2022. J Cell Physiol. 237:706. PubMed
  12. Mills EL, et al. 2022. Cell Metab. 34:140. PubMed
  13. Bettke JA, et al. 2022. Infect Immun. 90:e0007022. PubMed
  14. Madi A, et al. 2022. Int J Cancer. 151:797. PubMed
  15. Yue Y, et al. 2022. Nat Biomed Eng. 6:898. PubMed
  16. Sulaj A, et al. 2022. J Clin Endocrinol Metab. 107:2167. PubMed
  17. Brog RA, et al. 2022. Cancer Immunol Res. 10:962. PubMed
  18. Chen ML, et al. 2022. Mol Cancer Ther. 21:1337. PubMed
  19. Yin XY, et al. 2023. Neural Regen Res. 18:213. PubMed
  20. Gutierrez WR, et al. 2022. JCI Insight. 7: . PubMed
  21. Wang Y, et al. 2022. Front Endocrinol (Lausanne). 13:1036517. PubMed
  22. Koutník J, et al. 2022. Front Immunol. 13:1049033. PubMed
  23. Minott JA, et al. 2022. Front Immunol. 13:1038340. PubMed
  24. Tan TCJ, et al. 2022. Nat Commun. 13:7796. PubMed
  25. Noh J, et al. 2022. Cancers (Basel). 14: . PubMed
  26. Phares TW, et al. 2022. Front Pharmacol. 13:1029636. PubMed
  27. Zhao X, et al. 2022. STAR Protoc. 3:101859. PubMed
  28. Chan L, et al. 2022. Cells. 12: . PubMed
  29. Qin S, et al. 2023. Acta Pharm Sin B. :. PubMed
  30. Gong HH, et al. 2023. Front Immunol. 13:1089064. PubMed
  31. Teplensky MH, et al. 2023. Nat Biomed Eng. :. PubMed
  32. Sun L, et al. 2023. Mol Med Rep. 27: . PubMed
  33. Chan L, et al. 2023. Int J Mol Sci. 24: . PubMed
  34. Wang L, et al. 2023. Oxid Med Cell Longev. 2023:6480848. PubMed
  35. Xiao JF, et al. 2022. Mol Cancer Res. 20:637. PubMed
  36. Zander R, et al. 2022. Immunity. 55:475. PubMed
  37. Zhang H, et al. 2022. J Exp Med. 219:. PubMed
  38. Bronge M, et al. 2022. Sci Adv. 8:eabn1823. PubMed
  39. Zhuo Y, et al. 2022. J Immunother Cancer. 10:. PubMed
  40. Tipanee J, et al. 2022. Mol Ther. 30:3155. PubMed
  41. Tang J, et al. 2022. Sci Immunol. 7:eadd4853. PubMed
  42. de Groot AE, et al. 2022. Neoplasia. 32:100830. PubMed
  43. Hajnik RL, et al. 2022. Sci Transl Med. 14:eabq1945. PubMed
  44. Frost JN, et al. 2022. Sci Adv. 8:eabq5384. PubMed
  45. Li L, et al. 2022. Cancer Immunol Res. 10:1475. PubMed
  46. Chernozem RV, et al. 2023. Adv Healthc Mater. 12:e2201726. PubMed
  47. Gao L, et al. 2023. J Nanobiotechnology. 21:56. PubMed
  48. Kodama N, et al. 2023. Front Nutr. 10:1081263. PubMed
  49. Humphries DC, et al. 2023. Front Immunol. 14:1100161. PubMed
  50. Wang H, et al. 2023. Nature. 615:339. PubMed
  51. Gayet RV, et al. 2023. Nat Commun. 14:1339. PubMed
  52. Varun K, et al. 2023. EBioMedicine. 90:104516. PubMed
  53. Wang YH, et al. 2023. Int J Mol Sci. 24:. PubMed
  54. Deng G, et al. 2023. Cancers (Basel). 15:. PubMed
  55. Wang Y, et al. 2023. iScience. 26:106630. PubMed
  56. Xie J, et al. 2023. Mol Ther Oncolytics. 29:61. PubMed
  57. Amirova KM, et al. 2023. Int J Mol Sci. 24:. PubMed
  58. Ruan H, et al. 2023. Acta Pharm Sin B. 13:2202. PubMed
  59. Zhang TR, et al. 2023. Pharmaceuticals (Basel). 16:. PubMed
  60. Shou J, et al. 2023. Sci Adv. 9:eade9118. PubMed
  61. Michalaki C, et al. 2022. Curr Protoc. 2:e505. PubMed
  62. Li Q, et al. 2022. Cell Rep. 40:111308. PubMed
  63. Albaghdadi AJH, et al. 2022. Int J Mol Sci. 23:. PubMed
  64. van Vloten JP, et al. 2022. J Immunother Cancer. 10:. PubMed
  65. Zhang L, et al. 2021. J Immunol. 207:590. PubMed
  66. Li X, et al. 2022. Nat Commun. 13:2794. PubMed
  67. Ede J, et al. 2015. Toxicol Sci. 148: 108 - 120. PubMed
  68. Spitzer SO, et al. 2019. Neuron. 101:459. PubMed
  69. Li L,et al. 2017. Sci Rep.. 10.1038/s41598-017-14000-z. PubMed
  70. Lentucci C, et al. 2017. J Biol Chem. 292:2754-2772. PubMed
  71. Garton J, et al. 2021. Immunohorizons. 5:802. PubMed
  72. Duan Q, et al. 2021. Front Cell Dev Biol. 9:761193. PubMed
  73. Stegelmeier AA, et al. 2022. Biomedicines. 10:. PubMed
  74. Thaker YR, et al. 2022. Front Oncol. 12:884196. PubMed
  75. de Groot AE, et al. 2021. Prostate. 81:629. PubMed
  76. Busskamp V, et al. 2014. Mol Syst Biol. 10:760. PubMed
  77. Angiari S, et al. 2020. Cell Metab. 31:391. PubMed
  78. Kuo T, et al. 2017. Oncogene. 10.1038/onc.2017.156. PubMed
  79. Jimenez-Duran G, et al. 2020. EBioMedicine. 61:103039. PubMed
  80. Zhang Y, et al. 2020. Oncol Lett. 1.053472222. PubMed
  81. Lownik JC, et al. 2020. Biochem Biophys Res Commun. 522:442. PubMed
  82. Zhang S, et al. 2022. Cell Death Dis. 13:844. PubMed
  83. Tsai CY, et al. 2022. J Biomed Sci. 29:47. PubMed
  84. van der Heide V, et al. 2022. Cell Rep. :110508. PubMed
  85. Wright A, et al. 2015. Immunobiology. 220: 859-864. PubMed
  86. Martinez-Usatorre A, et al. 2020. Front Immunol. 11:340. PubMed
  87. Martinez–Usatorre A, et al. 2019. Cancer Immunol Res. 0.995138889. PubMed
  88. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  89. Brooks JF, et al. 2020. J Immunol. 205:1239. PubMed
  90. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  91. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  92. Bawazir M, et al. 2022. Front Immunol. 13:1033794. PubMed
  93. Bayer AL, et al. 2022. Cancers (Basel). 14:. PubMed
  94. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  95. Guye P, et al. 2016. Nat Commun. 7:10243. PubMed
  96. Haryadi L, et al. 2019. Vet World. 12:1529. PubMed
  97. Eslani M,et al. 2017. Invest Ophthalmol Vis Sci.. 58(12):5507-5517. PubMed
  98. Tang B, et al. 2020. Clin Cancer Res. 26:2216. PubMed
  99. Jtte BB, et al. 2021. iScience. 24(8):102833. PubMed
  100. Herda S, et al. 2021. Int J Cancer. 148:3097. PubMed
  101. Su W, et al. 2022. Front Immunol. 13:952338. PubMed
  102. Datta A, et al. 2022. J Fungi (Basel). 8:. PubMed
  103. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  104. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  105. Shamsi F, et al. 2021. Nat Metab. 3:485. PubMed
  106. Zhang X, et al. 2020. J Immunol. 205:1743. PubMed
  107. Subham S, et al. 2022. Breast Cancer Res Treat. Online ahead of print. PubMed
  108. Zhang B, et al. 2022. J Exp Med. 219:. PubMed
  109. Callahan SM, et al. 2021. Curr Protoc. 1:e294. PubMed
  110. Huang M, et al. 2022. Adv Sci (Weinh). 9:e2101267. PubMed
  111. Klepsch V, et al. 2020. Cell Commun Signal. 18:08. PubMed
  112. Sullivan B, et al. 2010. Am J Pathol. 177:2837. PubMed
  113. Cheng K, et al. 2021. Nat Commun. 12:2041. PubMed
  114. Li FJ, et al. 2022. PLoS One. 17:e0277019. PubMed
  115. Zhang L, et al. 2021. Methods Mol Biol. 2388:175. PubMed
  116. Rada M, et al. 2021. Commun Biol. 4:950. PubMed
  117. Chakraborty S, et al. 2022. Sci Transl Med. . PubMed
  118. Leonard NA, et al. 2021. Cancers (Basel). 13:. PubMed
  119. Park HB, et al. 2020. Oncoimmunology. 9:1772663. PubMed
  120. Chen L, et al. 2021. Cell Death Differ. 28:1880. PubMed
  121. Takahashi K, et al. 2022. Cell Rep Methods. 2:100155. PubMed
  122. Elliott PR, et al. 2021. Cell Rep. 37:109777. PubMed
  123. Balan I, et al. 2022. Front Immunol. 13:940095. PubMed
  124. Bunting MD, et al. 2022. Sci Adv. 8:eabk3327. PubMed
  125. Jimenez RV, et al. 2019. Front Immunol. 1.932638889. PubMed
  126. Cho S, et al. 2017. Sci Rep. 7:35. PubMed
  127. Callahan S, et al. 2020. Cell Microbiol. 22:e13210. PubMed
  128. Li J, et al. 2022. J Tissue Eng. 13:20417314221127908. PubMed
  129. Yang J, et al. 2022. Microbiome. 10:149. PubMed
  130. Alvandi Z, et al. 2022. J Am Heart Assoc. 11:e023695. PubMed
  131. Lamb C, et al. 2016. J Crohns Colitis. 10.1093/ecco-jcc/jjw189. PubMed
  132. Xu Z, et al. 2016. Nat Commun. 7:10728. PubMed
  133. van Duijn A, et al. 2021. Cancer Immunol Immunother. Online ahead of print. PubMed
  134. Jakic B, et al. 2021. Cell Death Dis. 12:187. PubMed
  135. Wei W, et al. 2022. mSystems. 7:e0046922. PubMed
  136. Zhao X, et al. 2022. Nat Protoc. 17:2240. PubMed
  137. Williamson LM, et al. 2021. NPJ Precis Oncol. 5:103. PubMed
  138. Gunasena M, et al. 2022. Sci Rep. 12:12377. PubMed
  139. Hornigold K, et al. 2022. Front Immunol. 13:888415. PubMed
  140. Yang B, et al. 2022. Bioengineered. 13:2685. PubMed
  141. Bekeschus S, et al. 2016. J Leukoc Biol. 100: 791 - 799. PubMed
  142. Li Q, et al. 2017. Front Immunol. 0.797916667. PubMed
  143. Willis RA, et al. 2021. Curr Protoc. 1:e36. PubMed
  144. Chen DL, et al. 2021. Mol Cancer. 20:166. PubMed
  145. Liu X, et al. 2016. Sci Rep. 6:36722. PubMed
  146. Rio M, et al. 2012. J Immunol. 188:4885. PubMed
  147. Kundu K, et al. 2019. Cancer Immunol Res. 1.069444444. PubMed
  148. Bajpai G, et al. 2018. Nat Med. 24:1234. PubMed
  149. Wilmes A, et al. 2017. Toxicol In Vitro. 10.1016/j.tiv.2017.07.023. PubMed
  150. Lundtoft C, et al. 2017. PLoS Pathogens. 13(6):e1006425. PubMed
  151. Wang L, et al. 2020. EMBO J. 39:e104514. PubMed
  152. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  153. Wen T, et al. 2022. Cancer Immunol Res. 10:162. PubMed
  154. Ma K, et al. 2022. iScience. 25:104347. PubMed
  155. Constant DA, et al. 2022. Immunohorizons. 6:416. PubMed
  156. Koyama T, et al. 2022. Curr Issues Mol Biol. 44:3146. PubMed
  157. Chen YF, et al. 2019. J Biomed Sci. 26:85. PubMed
  158. Rio M, et al. 2011. Transplantation. 92:1085. PubMed
  159. Dominguez CX, et al. 2020. Cancer Discov. 0.577777778. PubMed
  160. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  161. Hiza H, et al. 2021. Sci Rep. 11:13190. PubMed
  162. Mirlekar B, et al. 2022. Cell Rep Med. :100744. PubMed
  163. Rive CM, et al. 2022. Mol Ther Methods Clin Dev. 26:4. PubMed
  164. Bruno MEC, et al. 2022. Geroscience. 44:1761. PubMed
  165. Teh MR, et al. 2021. Front Immunol. 12:714613. PubMed
  166. Yokota-Nakatsuma A, et al. 2016. Sci Rep. 6:37914. PubMed
  167. Kenna T, et al. 2010. J Immunol. 184:598. PubMed
  168. Kakiyama G, et al. 2020. J Lipid Res. 61:1629. PubMed
  169. Wang Y, et al. 2020. Virol Sin. 36:122. PubMed
  170. Gutierrez WR, et al. 2021. Sci Rep. 1.220833333. PubMed
  171. Dong M, et al. 2022. J Immunother Cancer. 10:. PubMed
  172. Gerson-Gurwitz A, et al. 2021. Front Oncol. 11:766298. PubMed
  173. Koutník J, et al. 2022. Cell Commun Signal. 20:54. PubMed
  174. Zhao X, et al. 2022. iScience. 25:104690. PubMed
  175. Cérbulo-Vázquez A, et al. 2022. PLoS One. 17:e0264566. PubMed
  176. Glaser K, et al. 2016. PLoS One. 11: 0146898. PubMed
  177. Ansari M, et al. 2017. Cell Signal. 10.1016/j.cellsig.2017.04.014. PubMed
  178. Ahmad S, et al. 2017. Prog Neuropsychopharmacol Biol Psychiatry. 10.1016/j.pnpbp.2017.06.034. PubMed
  179. Park SR, et al. 2020. Cell Rep. 32:108077. PubMed
  180. Woo MS, et al. 2021. J Exp Med. :218. PubMed
  181. Chen RH, et al. 2021. Front Immunol. 11:594775. PubMed
  182. Rhoades NS, et al. 2022. Cell Rep. 39:110725. PubMed
  183. Tatangelo V, et al. 2022. Front Oncol. 12:877495. PubMed
  184. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  185. Kissel T, et al. 2022. Sci Adv. 8:eabm1759. PubMed
  186. Deng Y, et al. 2021. Nat Commun. 12:7041. PubMed
  187. Haunerdinger V, et al. 2021. Front Immunol. 12:740047. PubMed
  188. Lownik JC, et al. 2020. Biochem Biophys Rep. 24:100803. PubMed
  189. Labi V, et al. 2019. Genes Dev. 33:1673. PubMed
  190. Gensterblum E,et al. 2017. J Autoimmun.. 10.1016/j.jaut.2017.09.011. PubMed
  191. Zischke J, et al. 2017. PLoS Pathogens. 13(6):e1006454. PubMed
  192. DiMuzio JM, et al. 2021. Vaccine X. 8:100098. PubMed
  193. Lei L, et al. 2021. Front Cell Dev Biol. 659744:9. PubMed
  194. Frafjord A, et al. 2020. Scand J Immunol. e12889:92. PubMed
  195. Sun F, et al. 2022. Cell Death Dis. 13:181. PubMed
  196. Wang YJ, et al. 2021. Sci Rep. 11:8054. PubMed
  197. Wawrzyniak M, et al. 2021. Pharmacol Res Perspect. 9:e00837. PubMed
  198. Sun Y, et al. 2022. iScience. 25:104846. PubMed
  199. Wang X, et al. 2022. Elife. 11:. PubMed
  200. Swarnalekha N, et al. 2021. Sci Immunol. 6:. PubMed
  201. Marongiu L, et al. 2013. PLoS One. 8:75684. PubMed
  202. Nouraei N,et al. 2017. Exp Neurol.. 10.1016/j.expneurol.2017.10.017. PubMed
  203. Witt G, et al. 2020. Cell Biol Toxicol. . PubMed
  204. Zhang Z, et al. 2021. Front Immunol. 12:699478. PubMed
  205. Spiljar M, et al. 2021. Cell Metab. 33:2231. PubMed
  206. Chen Y, et al. 2021. Braz J Med Biol Res. 54:e9570. PubMed
  207. Xiao C, et al. 2021. STAR Protoc. 2:100789. PubMed
  208. Clancy-Thompson E, et al. 2015. Cancer Immunol Res. 3: 956-967. PubMed
  209. Wang L, et al. 2016. Oncogene. 10.1038/onc.2016.380. PubMed
  210. Melcher M, et al. 2017. Stem Cell Res Ther . 10.1186/s13287-017-0601-7. PubMed
  211. Guo Z, et al. 2022. Neurobiol Pain. 12:100096. PubMed
  212. Yoshikawa AM, et al. 2021. Nat Commun. 12:7106. PubMed
  213. Ikebuchi R, et al. 2016. Sci Rep. 6:35002. PubMed
  214. Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed
  215. Nightingale K, et al. 2018. Cell Host Microbe. 24:447. PubMed

Antigen Details

Antigen References

1. Current Protocols in Immunology (John Wiley & Sons New York) Unit 6.24 Detection of Intracellular Cytokines by Flow Cytometry (Barbara Foster and Calman Prussin NIAID NIH Bethesda MD).
2. Sander B, et al. 1991. Immunol. Rev. 119:65.
3. Sander B, et al. 1993. J. Immunol. Meth. 166:201.
4. Prussin C, et al. 1995. J. Immunol. Meth. 188:117.

Gene ID
NA

Related FAQs

There are no FAQs for this product.
Go To Top Version: 4    Revision Date: 07/25/2022

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account